Kevin Norrett

Kevin Norrett's Title

Kevin Norrett currently holds the position of Chief Operating Officer. With over two decades of experience in the biotechnology sector, he has demonstrated exceptional leadership in commercial strategy, business operations, and corporate development. His extensive background makes him an invaluable asset to any organization he is part of.

Kevin Norrett's Company

Kevin Norrett has held prominent roles in several leading biotechnology companies. Most recently, he served as the Chief Business Officer of Sierra Oncology, where he played a pivotal role in the company’s $1.9 billion acquisition by GSK. His previous positions include Chief Commercial Officer at Angion Biomedica and Vice President roles at Aimmune Therapeutics and ZS Pharma. His contributions have been instrumental in the success and growth of these companies.

Kevin Norrett's Achievements

Kevin Norrett has a remarkable track record of achievements in the biotechnology industry. At Sierra Oncology, he led commercial operations and corporate development, culminating in a $1.9 billion acquisition by GSK. As Chief Commercial Officer at Angion Biomedica, he set the commercial strategy that led to a successful IPO. At Aimmune Therapeutics, he built the commercial operations for the launch of Palforzia, the first approved therapy for pediatric peanut allergy. His strategic leadership at ZS Pharma contributed to its acquisition by AstraZeneca for $2.7 billion. His career is marked by significant contributions and successful transactions.

Kevin Norrett's Education and Expertise

Kevin Norrett boasts a robust educational background, holding an M.B.A. from the Haas School of Business at the University of California, Berkeley. He also earned an M.S. in Biochemistry and Molecular Biology from the University of California, Los Angeles, and a B.S. in Biological Sciences from the University of California, Davis. His strong academic foundation in both business and life sciences has equipped him with a unique expertise that he has leveraged throughout his career in the biotechnology industry.

Kevin Norrett's Background

Kevin Norrett began his career in the biotechnology sector with senior commercial leadership roles at Exelixis and Genentech, where he launched multiple products in oncology and rare diseases. He also served as an Associate in SG Cowen's Health Care Investment Banking Group, closing over 20 transactions worth over $2 billion. His extensive experience spans across various facets of the industry, including marketing, market access, commercial operations, and corporate development, making him a seasoned professional with a deep understanding of the biotechnology landscape.